OnlyFibs
$EXOZ | Fundamental & Technical Breakdown 📊🧪
• Business Overview: Development-stage synthetic biology company focused on enzymatic platforms for scalable biological molecule discovery.
• Profitability & Financials: Unprofitable. Early-stage micro-cap company with no active commercial revenue, operating with net losses (~-$1.20 EPS).
• Latest Earnings Report: Missed/Unprofitable (Reported EPS of -$0.33 with zero revenue).
• Wall Street Analyst Consensus: Unrated / Low Coverage. Limited institutional analyst coverage given small market cap (~$57M).
• Overall Bias: Cautiously Speculative / Bottoming Watch (Technicals compressing in a falling wedge near $6.10 support; breakout triggers above $7.50).
Key Levels for Bulls & Bears:
• Bull Reclaim Trigger: $7.50 / $8.20
• Overhead Targets: $9.10 / $10.15
• Critical Support Pivot: $6.10
• Bearish Invalidation Level: $5.90 / $4.35
#EXOZ #biotech #smallcaps #fundamentalanalysis #hovdid
